This showed no conclusive evidence of shared causal variants between LDL-C and oral/oropharyngeal cancer, with posterior probabilities of 0.055 for PCSK9 and 0.026 for LDLR, respectively (S12 Table). Here, PCSK9 is linked to oropharynx cancer.